title: Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis.
abstract: The differential diagnosis of clear cell, papillary, and chromophobe renal cell carcinoma is clinically important, because these tumor subtypes are associated with different pathobiology and clinical behavior. For cases in which histopathology is equivocal, immunohistochemistry and quantitative reverse transcriptase-polymerase chain reaction can assist in the differential diagnosis by measuring expression of subtype-specific biomarkers. Several renal tumor biomarkers have been discovered in expression microarray studies. However, due to heterogeneity of gene and protein expression, additional biomarkers are needed for reliable diagnostic classification. We developed novel bioinformatics systems to identify candidate renal tumor biomarkers from the microarray profiles of 45 clear cell, 16 papillary, and 10 chromophobe renal cell carcinomas; the microarray data was derived from 2 independent published studies. The ArrayWiki biocomputing system merged the microarray data sets into a single file, so gene expression could be analyzed from a larger number of tumors. The caCORRECT system removed non-random sources of error from the microarray data, and the omniBioMarker system analyzed data with several gene-ranking algorithms to identify algorithms effective at recognizing previously described renal tumor biomarkers. We predicted these algorithms would also be effective at identifying unknown biomarkers that could be verified by independent methods. We selected 6 novel candidate biomarkers from the omniBioMarker analysis and verified their differential expression in formalin-fixed paraffin-embedded tissues by quantitative reverse transcriptase-polymerase chain reaction and immunohistochemistry. The candidate biomarkers were carbonic anhydrase IX, ceruloplasmin, schwannomin-interacting protein 1, E74-like factor 3, cytochrome c oxidase subunit 5a, and acetyl-CoA acetyltransferase 1. Quantitative reverse transcriptase-polymerase chain reaction was performed on 17 clear cell, 13 papillary and 7 chromophobe renal cell carcinoma. Carbonic anhydrase IX and ceruloplasmin were overexpressed in clear cell renal cell carcinoma; schwannomin-interacting protein 1 and E74-like factor 3 were overexpressed in papillary renal cell carcinoma; and cytochrome c oxidase subunit 5a and acetyl-CoA acetyltransferase 1 were overexpressed in chromophobe renal cell carcinoma. Immunohistochemistry was performed on tissue microarrays containing 66 clear cell, 16 papillary, and 12 chromophobe renal cell carcinomas. Cytoplasmic carbonic anhydrase IX staining was significantly associated with clear cell renal cell carcinoma. Strong cytoplasmic schwannomin-interacting protein 1 and cytochrome c oxidase subunit 5a staining were significantly more frequent in papillary and chromophobe renal cell carcinoma, respectively. In summary, we developed a novel process for identifying candidate renal tumor biomarkers from microarray data, and verifying differential expression in independent assays. The tumor biomarkers have potential utility as a multiplex expression panel for classifying renal cell carcinoma with equivocal histology. Biomarker expression assays are increasingly important for renal cell carcinoma diagnosis, as needle core biopsies become more common and different therapies for tumor subtypes continue to be developed.
authors.affiliation: Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
authors.forename: Adeboye O
authors.initials: AO
authors.lastname: Osunkoya
authors.forename: Qiqin
authors.initials: Q
authors.lastname: Yin-Goen
authors.forename: John H
authors.initials: JH
authors.lastname: Phan
authors.forename: Richard A
authors.initials: RA
authors.lastname: Moffitt
authors.forename: Todd H
authors.initials: TH
authors.lastname: Stokes
authors.forename: May D
authors.initials: MD
authors.lastname: Wang
authors.forename: Andrew N
authors.initials: AN
authors.lastname: Young
mesh_terms: D000465:Algorithms; D014408:Biomarkers, Tumor / Q000032:analysis*; D002292:Carcinoma, Renal Cell / Q000175:diagnosis* / Q000235:genetics / Q000378:metabolism; D019295:Computational Biology / Q000379:methods*; D003937:Diagnosis, Differential; D015870:Gene Expression; D020869:Gene Expression Profiling; D006801:Humans; D007150:Immunohistochemistry; D007680:Kidney Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000378:metabolism; D020411:Oligonucleotide Array Sequence Analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D014408:Biomarkers, Tumor
references.citation: Eur J Cancer. 2005 Dec;41(18):2935-47
references.pmid: 16310354
references.citation: Oncogene. 2000 Apr 6;19(15):1941-9
references.pmid: 10773884
references.citation: Int J Cancer. 2008 Jul 15;123(2):395-400
references.pmid: 18464292
references.citation: Am J Surg Pathol. 2002 Apr;26(4):403-12
references.pmid: 11914617
references.citation: Nature. 2007 Feb 15;445(7129):691
references.pmid: 17301755
references.citation: Oncogene. 2002 May 30;21(24):3934-8
references.pmid: 12032832
references.citation: J Clin Oncol. 2002 May 1;20(9):2376-81
references.pmid: 11981011
references.citation: J Pathol. 2005 Feb;205(3):377-87
references.pmid: 15682440
references.citation: Conf Proc IEEE Eng Med Biol Soc. 2006;2006:3325-8
references.pmid: 17947022
references.citation: BMC Bioinformatics. 2008 May 28;9 Suppl 6:S18
references.pmid: 18541053
references.citation: Prostate. 2008 Jan 1;68(1):20-33
references.pmid: 18000807
references.citation: Nat Protoc. 2007;2(5):1152-65
references.pmid: 17546006
references.citation: J Biol Chem. 2001 Jun 15;276(24):20989-98
references.pmid: 11399774
references.citation: Am J Pathol. 2001 Feb;158(2):419-29
references.pmid: 11159180
references.citation: Cancer Lett. 1997 Dec 23;121(2):139-45
references.pmid: 9570351
references.citation: Genome Biol. 2007;8(1):102
references.pmid: 17274839
references.citation: J Mol Diagn. 2005 May;7(2):206-18
references.pmid: 15858144
references.citation: Brief Bioinform. 2006 Jun;7(2):166-77
references.pmid: 16772260
references.citation: Conf Proc IEEE Eng Med Biol Soc. 2006;2006:3317-20
references.pmid: 17947020
references.citation: Indian J Physiol Pharmacol. 2003 Jan;47(1):108-10
references.pmid: 12708132
references.citation: Clin Cancer Res. 2003 Feb;9(2):802-11
references.pmid: 12576453
references.citation: J Urol. 2006 Jun;175(6):2302-6
references.pmid: 16697863
references.citation: Biostatistics. 2003 Apr;4(2):249-64
references.pmid: 12925520
references.citation: Clin Cancer Res. 2005 Aug 15;11(16):5730-9
references.pmid: 16115910
references.citation: Oncogene. 1997 Nov 13;15(20):2449-62
references.pmid: 9395241
references.citation: Mol Cell Biol. 2000 Mar;20(5):1699-712
references.pmid: 10669747
references.citation: Oncogene. 2003 Oct 2;22(43):6810-8
references.pmid: 14555994
references.citation: Annu Int Conf IEEE Eng Med Biol Soc. 2007;2007:4633-6
references.pmid: 18003038
references.citation: BMC Evol Biol. 2008 Jan 15;8:8
references.pmid: 18197981
references.citation: Oncogene. 2000 Dec 18;19(55):6490-502
references.pmid: 11175365
references.citation: Ann Surg Oncol. 2004 Jan;11(1):71-7
references.pmid: 14699037
references.citation: J Trace Elem Med Biol. 2001;15(2-3):193-6
references.pmid: 11787988
references.citation: Am J Pathol. 2003 Mar;162(3):925-32
references.pmid: 12598325
references.citation: Genome Biol. 2003;4(4):R28
references.pmid: 12702209
references.citation: Clin Cancer Res. 2001 Jul;7(7):2145-51
references.pmid: 11448934
references.citation: Nat Biotechnol. 2008 Jan;26(1):83-90
references.pmid: 18157119
references.citation: Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14863-8
references.pmid: 9843981
references.citation: Hum Pathol. 2009 Feb;40(2):206-10
references.pmid: 18799195
references.citation: Proteomics. 2005 Aug;5(12):3205-13
references.pmid: 16003825
references.citation: Crit Rev Oncol Hematol. 2007 Aug;63(2):111-24
references.pmid: 17555981
references.citation: Oncogene. 2000 Jan 6;19(1):151-4
references.pmid: 10644990
references.citation: Indian J Physiol Pharmacol. 2004 Oct;48(4):486-8
references.pmid: 15907060
references.citation: Annu Rev Cell Dev Biol. 2006;22:129-57
references.pmid: 16753029
references.citation: Am J Surg Pathol. 2003 Feb;27(2):199-205
references.pmid: 12548166
references.citation: Am J Clin Pathol. 2005 Mar;123(3):421-9
references.pmid: 15716239
references.citation: Biochim Biophys Acta. 2008 Jan;1785(1):32-54
references.pmid: 17980164
references.citation: Br J Cancer. 2001 Nov 2;85(9):1372-82
references.pmid: 11720477
references.citation: Am J Surg Pathol. 2000 Sep;24(9):1247-56
references.pmid: 10976699
references.citation: Am J Surg Pathol. 2002 Mar;26(3):281-91
references.pmid: 11859199
references.citation: Clin Cancer Res. 2005 Sep 15;11(18):6558-66
references.pmid: 16166433
references.citation: Carcinogenesis. 2002 May;23(5):759-68
references.pmid: 12016148
references.citation: Eur Urol. 2008 Jun;53(6):1219-25
references.pmid: 18082317
references.citation: Am J Clin Pathol. 2004 Jun;121(6):878-83
references.pmid: 15198361
references.citation: Cancer Biol Ther. 2007 Jan;6(1):76-82
references.pmid: 17172821
references.citation: BJU Int. 2008 Jun;101 Suppl 4:25-30
references.pmid: 18430119
references.citation: Am J Pathol. 2001 May;158(5):1639-51
references.pmid: 11337362
references.citation: Ann Biomed Eng. 2007 Jun;35(6):1068-80
references.pmid: 17458699
references.citation: Int Urol Nephrol. 1997;29(4):427-32
references.pmid: 9405999
references.citation: Mol Cell Biol. 2004 Jun;24(12):5548-64
references.pmid: 15169914
references.citation: Turk J Gastroenterol. 2005 Jun;16(2):81-4
references.pmid: 16252197
references.citation: J Biol Chem. 2007 Jul 6;282(27):19820-30
references.pmid: 17491012
references.citation: Am J Surg Pathol. 2004 Jan;28(1):69-76
references.pmid: 14707866